Efficacy of Tadalafil/Solifenacin VS Tamsulosin/Solifenacin Combination Therapy for BPH/OAB
Status:
Active, not recruiting
Trial end date:
2022-08-01
Target enrollment:
Participant gender:
Summary
The investigators will compare the efficacy and safety of tadalafil/solifenacin combination
therapy versus tamsulosin/solifenacin combination therapy for the treatment of BPH/OAB in a
randomized controlled trial (RCT).